BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36335325)

  • 1. Patient-reported functional outcome measures and treatment choice for prostate cancer.
    Tiruye T; O'Callaghan M; Moretti K; Jay A; Higgs B; Santoro K; Boyle T; Ettridge K; Beckmann K
    BMC Urol; 2022 Nov; 22(1):169. PubMed ID: 36335325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
    Hoffman KE; Penson DF; Zhao Z; Huang LC; Conwill R; Laviana AA; Joyce DD; Luckenbaugh AN; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Koyama T; Barocas DA
    JAMA; 2020 Jan; 323(2):149-163. PubMed ID: 31935027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
    Barocas DA; Alvarez J; Resnick MJ; Koyama T; Hoffman KE; Tyson MD; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF
    JAMA; 2017 Mar; 317(11):1126-1140. PubMed ID: 28324093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results.
    Tyson MD; Koyama T; Lee D; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen V; Conwill R; McCollum D; Penson DF; Barocas DA
    Eur Urol; 2018 Jul; 74(1):26-33. PubMed ID: 29501451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported sexual quality of life after different types of radical prostatectomy and radiotherapy: Analysis of a population-based prospective cohort.
    Mullins BT; Basak R; Broughman JR; Chen RC
    Cancer; 2019 Oct; 125(20):3657-3665. PubMed ID: 31256432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.
    Lee WR; Hall MC; McQuellon RP; Case LD; McCullough DL
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):614-23. PubMed ID: 11597800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancer.
    Pasalic D; Barocas DA; Huang LC; Zhao Z; Koyama T; Tang C; Conwill R; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup AM; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Hoffman KE
    Cancer; 2021 Jun; 127(11):1912-1925. PubMed ID: 33595853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer.
    Chen RC; Basak R; Meyer AM; Kuo TM; Carpenter WR; Agans RP; Broughman JR; Reeve BB; Nielsen ME; Usinger DS; Spearman KC; Walden S; Kaleel D; Anderson M; Stürmer T; Godley PA
    JAMA; 2017 Mar; 317(11):1141-1150. PubMed ID: 28324092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study.
    De B; Pasalic D; Barocas DA; Wallis CJD; Huang LC; Zhao Z; Koyama T; Tang C; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Hoffman KE
    J Urol; 2022 Dec; 208(6):1226-1239. PubMed ID: 36006050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).
    Lane JA; Donovan JL; Young GJ; Davis M; Walsh EI; Avery KNL; Blazeby JM; Mason MD; Martin RM; Peters TJ; Turner EL; Wade J; Bollina P; Catto JWF; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Oxley J; Paul A; Paez E; Rosario DJ; Rowe E; Staffurth J; Neal DE; Hamdy FC; Metcalfe C;
    BJU Int; 2022 Sep; 130(3):370-380. PubMed ID: 35373443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer.
    Litwin MS; Gore JL; Kwan L; Brandeis JM; Lee SP; Withers HR; Reiter RE
    Cancer; 2007 Jun; 109(11):2239-47. PubMed ID: 17455209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification.
    Takizawa I; Hara N; Nishiyama T; Kaneko M; Hoshii T; Tsuchida E; Takahashi K
    Asian J Androl; 2009 May; 11(3):283-90. PubMed ID: 19349948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Patient-reported Outcomes After External Beam Radiation Therapy and Combined External Beam With Low-dose-rate Brachytherapy Boost in Men With Localized Prostate Cancer.
    Lee DJ; Barocas DA; Zhao Z; Huang LC; Resnick MJ; Koyoma T; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF; Hoffman KE
    Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):116-126. PubMed ID: 30102188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes.
    Huelster HL; Laviana AA; Joyce DD; Huang LC; Zhao Z; Koyama T; Hoffman KE; Conwill R; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg M; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
    Urol Oncol; 2020 Dec; 38(12):930.e23-930.e32. PubMed ID: 32736934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
    Kishan AU; Cook RR; Ciezki JP; Ross AE; Pomerantz MM; Nguyen PL; Shaikh T; Tran PT; Sandler KA; Stock RG; Merrick GS; Demanes DJ; Spratt DE; Abu-Isa EI; Wedde TB; Lilleby W; Krauss DJ; Shaw GK; Alam R; Reddy CA; Stephenson AJ; Klein EA; Song DY; Tosoian JJ; Hegde JV; Yoo SM; Fiano R; D'Amico AV; Nickols NG; Aronson WJ; Sadeghi A; Greco S; Deville C; McNutt T; DeWeese TL; Reiter RE; Said JW; Steinberg ML; Horwitz EM; Kupelian PA; King CR
    JAMA; 2018 Mar; 319(9):896-905. PubMed ID: 29509865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive quality-of-life outcomes in the setting of a multidisciplinary, equal access prostate cancer clinic.
    Rice K; Hudak J; Peay K; Elsamanoudi S; Travis J; Lockhart R; Cullen J; Black L; Houge S; Brassell S
    Urology; 2010 Nov; 76(5):1231-8. PubMed ID: 20579698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both.
    Jarosek SL; Virnig BA; Chu H; Elliott SP
    Eur Urol; 2015 Feb; 67(2):273-80. PubMed ID: 25217421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.
    Banerji JS; Hurwitz LM; Cullen J; Wolff EM; Levie KE; Rosner IL; Brand TC; LʼEsperance JO; Sterbis JR; Porter CR
    Urol Oncol; 2017 May; 35(5):234-242. PubMed ID: 28110975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality Radiotherapy.
    Tward JD; O'Neil B; Boucher K; Kokeny K; Lowrance WT; Lloyd S; Cannon D; Stephenson RA; Agarwal N; Farr T; Petragallo R; Sherar NZ; Kunz I; Hofer A; Courdy S; Shrieve DC; Dechet C
    Clin Genitourin Cancer; 2020 Aug; 18(4):274-283.e5. PubMed ID: 32335059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade.
    Jang JW; Drumm MR; Efstathiou JA; Paly JJ; Niemierko A; Ancukiewicz M; Talcott JA; Clark JA; Zietman AL
    Cancer Med; 2017 Jul; 6(7):1827-1836. PubMed ID: 28560840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.